Takeda Pharma AG - Elvanse 40 mg, Hartkapseln | | 63023 | | 05 | | Elvanse 40 mg | | Hartkapseln | | N06BA12 | | Lisdexamfetamine | | 16.11.2016 | | |
| Composition | lisdexamfetamini dimesilas 40 mg corresp. dexamfetaminum 11.9 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 133, E 171, E 172 (nigrum), E 172 (flavum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.3336 mg. | Packungsbestandteile | | Capsules | | | | | | Active Agent | Dose |
---|
Lisdexamfetamini Dimesilas | 40 mg correspond Dexamfetaminum 11.9 mg |
| BAG: Active Agent | Dose |
---|
Lisdexamfetamini Dimesilas | 40 mg |
| | Inactive agents | | additional_information |
---|
(Flavum) | | | (Nigrum) | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 133 | | color. | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Kalii Hydroxidum | | | Lacca | | Drucktinte | Magnesii Stearas | | | Propylenglycol | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
005 | 30 | 93.29 | 115.00 | A+ | SL | Yes |
|
|